Gimbal Financial Makes New $6.48 Million Investment in ARK Genomic Revolution ETF $ARKG

Gimbal Financial purchased a new position in ARK Genomic Revolution ETF (BATS:ARKG) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 119,474 shares of the company’s stock, valued at approximately $6,478,000. ARK Genomic Revolution ETF comprises about 3.8% of Gimbal Financial’s holdings, making the stock its 9th biggest position. Gimbal Financial owned 0.27% of ARK Genomic Revolution ETF at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Midwest Financial Partners Investments Inc. increased its holdings in ARK Genomic Revolution ETF by 2.1% during the first quarter. Midwest Financial Partners Investments Inc. now owns 209,416 shares of the company’s stock worth $5,533,000 after buying an additional 4,230 shares during the last quarter. Himension Capital Singapore PTE. LTD. bought a new stake in ARK Genomic Revolution ETF in the first quarter worth about $2,250,000. Baird Financial Group Inc. boosted its stake in ARK Genomic Revolution ETF by 0.3% in the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock valued at $3,101,000 after acquiring an additional 255 shares during the last quarter. Client First Investment Management LLC purchased a new position in ARK Genomic Revolution ETF in the second quarter valued at about $2,579,000. Finally, Wealthfront Advisers LLC boosted its stake in ARK Genomic Revolution ETF by 4.9% in the first quarter. Wealthfront Advisers LLC now owns 54,391 shares of the company’s stock valued at $1,437,000 after acquiring an additional 2,544 shares during the last quarter.

ARK Genomic Revolution ETF Stock Up 1.4%

Shares of ARK Genomic Revolution ETF stock traded up $0.66 on Monday, reaching $47.36. 2,613,432 shares of the company traded hands, compared to its average volume of 3,373,501. ARK Genomic Revolution ETF has a 52 week low of $24.60 and a 52 week high of $58.83. The company has a 50 day moving average of $48.87 and a 200 day moving average of $39.52.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.